HSD105 Cost Savings Benefits of Operational Waste Minimization in a Care Program by Cohorts of Babies on Treatment With Palivizumab

Autor: Herrera, R, Madrigal Cadavid, J, Hincapie, AM, Rendon, A, Tabares, JE, Abad, JM, Molina, F, Estrada Acevedo, JI, Giraldo, PA

Publikováno v: In Value in Health December 2022 25(12) Supplement:S293-S293

HSD23 Operational Waste Savings on Health in a Value-Based Patient Drug Safety Program

Autor: Tabares, JE, Madrigal Cadavid, J, Rendon, A, Hincapie, AM, Estrada Acevedo, JI, Giraldo, PA, Abad, JM, Molina, F

Publikováno v: In Value in Health December 2022 25(12) Supplement:S277-S277

The induction of SHP-1 degradation by TAOK3 ensures the responsiveness of T cells to TCR stimulation.

Autor: Poirier A; Goodman Cancer Institute, McGill University, Montréal, H3A 1A3 Québec, Canada.; Faculty of Medicine and Health Sciences, Division of Experimental Medicine, McGill University, Montréal, Québec, Canada., Ormonde JVS; Brazilian Biosciences National Laboratory, Center for Research in Energy and Materials (LNBio - CNPEM), Campinas, São Paulo, Brazil., Aubry I; Goodman Cancer Institute, McGill University, Montréal, H3A 1A3 Québec, Canada.; Department of Biochemistry, McGill University, Montréal, Québec, Canada., Abidin BM; Goodman Cancer Institute, McGill University, Montréal, H3A 1A3 Québec, Canada., Feng CH; Goodman Cancer Institute, McGill University, Montréal, H3A 1A3 Québec, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, Québec, Canada., Martinez-Cordova Z; Goodman Cancer Institute, McGill University, Montréal, H3A 1A3 Québec, Canada.; Department of Microbiology and Immunology, McGill University, Montréal, Québec, Canada., Hincapie AM; Goodman Cancer Institute, McGill University, Montréal, H3A 1A3 Québec, Canada.; Department of Biochemistry, McGill University, Montréal, Québec, Canada., Wu C; Department of Microbiology and Immunology, McGill University, Montréal, Québec, Canada., Pérez-Quintero LA; Goodman Cancer Institute, McGill University, Montréal, H3A 1A3 Québec, Canada., Wang CL; NYU Langone Medical Center, 660 1st Ave, Fl 5, New York City, NY 10016, USA., Gingras AC; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, Canada., Madrenas J; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 40095, USA., Tremblay ML; Goodman Cancer Institute, McGill University, Montréal, H3A 1A3 Québec, Canada.; Department of Biochemistry, McGill University, Montréal, Québec, Canada.; Faculty of Medicine, McGill University, Montréal, Québec, Canada.

Publikováno v: Science signaling [Sci Signal] 2024 Jan 02; Vol. 17 (817), pp. eadg4422. Date of Electronic Publication: 2024 Jan 02.

Biallelic variants in TRAPPC10 cause a microcephalic TRAPPopathy disorder in humans and mice.

Autor: Rawlins LE; RILD Wellcome Wolfson Medical Research Centre, RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Exeter, United Kingdom.; Peninsula Clinical Genetics Service, Royal Devon & Exeter Hospital (Heavitree), Exeter, United Kingdom., Almousa H; Department of Biology, Concordia University, Montreal, Quebec, Canada., Khan S; RILD Wellcome Wolfson Medical Research Centre, RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Exeter, United Kingdom.; Department of Biological Sciences, International Islamic University, Islamabad, Pakistan., Collins SC; Institute of Genetics and Molecular and Cellular Biology, Inserm, Illkirch, France.; Inserm, University of Bourgogne Franche-Comté, Dijon, France., Milev MP; Department of Biology, Concordia University, Montreal, Quebec, Canada., Leslie J; RILD Wellcome Wolfson Medical Research Centre, RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Exeter, United Kingdom., Saint-Dic D; Department of Biology, Concordia University, Montreal, Quebec, Canada., Khan V; Department of Molecular Diagnostics, Rehman Medical Institute, Peshawar, Pakistan., Hincapie AM; Department of Biology, Concordia University, Montreal, Quebec, Canada., Day JO; RILD Wellcome Wolfson Medical Research Centre, RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Exeter, United Kingdom.; Faculty of Health, University of Plymouth, Plymouth, United Kingdom., McGavin L; University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom., Rowley C; Wellcome Sanger Institute, Hinxton, Cambridge, United Kingdom., Harlalka GV; RILD Wellcome Wolfson Medical Research Centre, RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Exeter, United Kingdom.; Department of Pharmacology, Rajarshi Shahu College of Pharmacy, Malvihir, Buldana, India., Vancollie VE; Wellcome Sanger Institute, Hinxton, Cambridge, United Kingdom., Ahmad W; Department of Biochemistry, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan., Lelliott CJ; Wellcome Sanger Institute, Hinxton, Cambridge, United Kingdom., Gul A; Department of Biological Sciences, International Islamic University, Islamabad, Pakistan., Yalcin B; Institute of Genetics and Molecular and Cellular Biology, Inserm, Illkirch, France.; Inserm, University of Bourgogne Franche-Comté, Dijon, France., Crosby AH; RILD Wellcome Wolfson Medical Research Centre, RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Exeter, United Kingdom., Sacher M; Department of Biology, Concordia University, Montreal, Quebec, Canada.; Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada., Baple EL; RILD Wellcome Wolfson Medical Research Centre, RD&E (Wonford) NHS Foundation Trust, University of Exeter Medical School, Exeter, United Kingdom.; Peninsula Clinical Genetics Service, Royal Devon & Exeter Hospital (Heavitree), Exeter, United Kingdom.

Publikováno v: PLoS genetics [PLoS Genet] 2022 Mar 17; Vol. 18 (3), pp. e1010114. Date of Electronic Publication: 2022 Mar 17 (Print Publication: 2022).